Back to discover
Drug

Titanium

Preclinical / discovery stage
ResearchEarly translational research
RxNorm1305547UNIID1JT611TNE
4
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Multiple-Offset Titanium Slot-Stems Versus Limited-Offset Cobalt–Chromium Stems in Hybrid-Fixation Revision Total Knee Arthroplasty: A Comparative Study With 5- to 14-Year Follow-up

Research2026-10-16Research news · The Journal of Arthroplasty

Providence Medical Technology Receives FDA 510(k) Clearance for CORUS™ PCSS 3D-T, Bringing 3D-Printed Porous Titanium to Its Total Segmental Fusion Platform

Regulatory2026-10-13Regulatory news · Orthopedics This Week

Sub-10-nm stacking bands enable ultrastrong additively manufactured titanium

Industry2026-09-25Manufacturing · Nature Materials

Examining the impact of nano-titanium dioxide on the adhesion and failure behavior of asphalt mixtures in acid rain conditions

Industry2026-08-16Nature — Environmental Sciences

The effect of green carbon Dots/Titanium dioxide for photocatalytic reduction of CO2

Industry2026-08-03Nature — Environmental Sciences

Bio-Inspired Spike-Timing-Dependent Plasticity Learning with Metal Halide Perovskites: Toward Artificial Synaptic Functionality.

Research2026-01-21ACS applied materials & interfaces

Programmable metal-based immuno-photocatalytic nanoparticles for precision activation of anti-tumor immunity.

Research2025-10-14Journal of nanobiotechnology

An artificial spiking afferent nerve based on Mott memristors for neurorobotics.

Research2020-01-02Nature communications

Lead iodide perovskite sensitized all-solid-state submicron thin film mesoscopic solar cell with efficiency exceeding 9%.

Research2012-08-21Scientific reports

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Titanium
RxNorm CUI
1305547
UNII
D1JT611TNE

Research activity

4 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
2012–2026
Major research themes8
Afferent Pathways1Calcium Compounds1Energy-Generating Resources1Immunotherapy1Metal Nanoparticles1Nanoparticles1Neoplasms1Neural Networks, Computer1
Journals, researchers & institutions
Top journals
  • ACS applied materials & interfaces1
  • Journal of nanobiotechnology1
  • Nature communications1
  • Scientific reports1
Leading researchers
  • Yang Y2
  • Ashrafizadeh M1
  • Bisquert J1
  • Fang Y1
  • Grätzel M1
  • Han M1
  • Hou Y1
  • Humphry-Baker R1
Leading institutions
free-text, unnormalised
  • Biomedical Research Networking Centre in Bioengineering1
  • Harbin Medical University Cancer Hospital1
  • Hepato-Pancreato-Biliary Center1
  • Hunan University of Medicine General Hospital1
  • Instituto de Microelectrónica de Sevilla1
  • Instituto de Tecnología Química (ITQ)1

Related drugs

5 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Titanium dioxide

Studied across the same disease area as Titanium in the shared literature.

1 shared disease1 shared paper
Calcium Compounds

Frequently co-studied with Titanium in the research literature.

2 shared papers
Iodides

Frequently co-studied with Titanium in the research literature.

1 shared paper
Lead

Frequently co-studied with Titanium in the research literature.

1 shared paper
Niobium

Frequently co-studied with Titanium in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature